From buyouts to sales, from initial public offerings (IPOs) to the U.S. Food and Drug Administration (FDA) approval, a life sciences company may experience several major business events throughout its lifecycle. With each of these milestones comes significant risk and legal uncertainty. Fortunately, life sciences business owners and leaders can count on assistance from experienced legal advisors such as Herbert Fineburg of Offit Kurman.

Mr. Fineburg recently joined with professionals from Morgan Stanley to present “About to be Flush: How to Play a Winning Hand,” an interactive panel hosted by Life Sciences PA. His fellow presenters included Morgan Stanley executive directors Joseph Romano (who also serves as Head of the Wealth Planning Center for the Mid-Atlantic Region) and Eric Salmansohn (who also serves as Family Wealth Director, Senior Investment Management Consultant, and Financial Advisor),  Continue reading....